Duane Morris Class Action Review - 2023 - Report - Page 291
1. $7.4 billion – In Re National Prescription Opiate Litigation, Case No. 17-MD02804 (N.D. Ohio Feb. 25, 2022) (settlement agreement reached with distributor
McKesson to resolve the vast majority of the opioid lawsuits filed by state and
local governmental entities).
2. $6.1 billion – In Re National Prescription Opiate Litigation, Case No. 17-MD02804 (N.D. Ohio Feb. 25, 2022) (settlement agreement reached with distributor
AmerisourceBergen to resolve the vast majority of the opioid lawsuits filed by
state and local governmental entities).
3. $6 billion – In Re National Prescription Opiate Litigation, Case No. 17-MD02804 (N.D. Ohio Feb. 25, 2022) (settlement agreement reached with distributor
Cardinal Health to resolve the vast majority of the opioid lawsuits filed by state
and local governmental entities).
4. $5.5 billion – In Re National Prescription Opiate Litigation, Case No. 17-MD02804 (N.D. Ohio Mar. 3, 2022) (settlement agreement reached with 13 states
by OxyContin manufacturer Purdue Pharma to resolve claims that the company
held to fuel the U.S. opioid epidemic).
290
© Duane Morris LLP 2023
Duane Morris Class Action Review – 2023
